Logo
PEPTIDE-BASED GASTROINTESTINAL DISORDERS THERAPEUTICS MARKET ANALYSIS
  2. / Market Insights
  3. Peptide-Based Gastrointestinal Disorders Therapeutics Market Analysis
all report title image

PEPTIDE-BASED GASTROINTESTINAL DISORDERS THERAPEUTICS MARKET ANALYSIS

Peptide-Based Gastrointestinal Disorders Therapeutics Market, by Drugs (Plecanatide (Trulance), Teduglutide, and Linaclotide), by Application (Short Bowel Syndrome, Chronic Constipation, Irritable Bowel Syndrome, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Oct 2024
  • Code : CMI2028
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Peptide-Based Gastrointestinal Disorders Therapeutics Market Key Players

Key players operating in the global peptide-based gastrointestinal disorders therapeutics market include Ironwood Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Astellas Pharma Inc., Allergan plc., and Cipher Pharmaceuticals Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.